Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to home with home health service. admission_source:  Physician Referral. Number of days between admission and discharge: 8. Payer code: Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 40. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 155. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No.